Presentation
Mablink Bioscience is focused on the immunotherapy of cancer. Mablink brings to the market a disruptive technology for the development of Antibody Drug Conjugates (ADC) candidates.
Contact
Address
Espace Deskeo, 69 rue de la République, 69002 LYON – FRANCE
Website
Targeted indications : breast cancer, lung cancer, colorectal cancer, prostate cancer, stomach cancer, supportive care, liver cancer, brain cancer, head & neck cancer, gastrointestinal cancer, gynecological cancer, bone cancer, genitourinary cancer, skin cancer, hematologic cancer, lymphoma, myeloma, leukemia, predictive toxicology.